Literature DB >> 18293018

Detection of measles- and mumps-specific IgG antibodies in paired serum and oral fluid samples from Norwegian conscripts.

K Vainio1, H H Samdal, G Anestad, E Wedege, D H Skutlaberg, K T Bransdal, R Mundal, I S Aaberge.   

Abstract

The aim of this study was to measure the seroprevalence to mumps in Norwegian conscripts belonging to the first children vaccination cohorts that had been offered two doses of MMR vaccine. The seroprevalence to mumps was 76% with the Microimmune assay and 85% with the Enzygnost assay. We also compared the performance of the Microimmune assay for detection of mumps- and measles-specific IgG antibodies in 340 paired serum and oral fluid samples from the conscripts and evaluated the effect of revaccination. Mumps-specific IgG antibodies were detected in only 61% of the oral fluids. In contrast, high levels of measles-specific IgG antibodies were detected in both the serum and oral fluid samples. Based on these results, we are only able to recommend the use of oral fluid for surveillance of measles in Norway. Our results may also indicate that the seroprevalence necessary to interrupt transmission of mumps has not been reached in vaccinated young adult Norwegians. Seroconversion was observed in all initially measles seronegative conscripts after revaccination, whereas 23 of 27 initially mumps seronegative conscripts failed to seroconvert.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18293018     DOI: 10.1007/s10096-008-0460-3

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  22 in total

1.  Detection of measles specific IgG in oral fluid using an FITC/anti-FITC IgG capture enzyme linked immunosorbent assay (GACELISA).

Authors:  W Nigatu; D J Nokes; F Enquselassie; D W Brown; B J Cohen; A J Vyse; F T Cutts
Journal:  J Virol Methods       Date:  1999-12       Impact factor: 2.014

2.  Has oral fluid the potential to replace serum for the evaluation of population immunity levels? A study of measles, rubella and hepatitis B in rural Ethiopia.

Authors:  D J Nokes; F Enquselassie; W Nigatu; A J Vyse; B J Cohen; D W Brown; F T Cutts
Journal:  Bull World Health Organ       Date:  2001       Impact factor: 9.408

Review 3.  Detection of antibodies in saliva--an effective auxiliary method in surveillance of infectious diseases.

Authors:  R Madar; S Straka; T Baska
Journal:  Bratisl Lek Listy       Date:  2002       Impact factor: 1.278

4.  Improving sensitivity of oral fluid testing in IgG prevalence studies: application of mixture models to a rubella antibody survey.

Authors:  N J Gay; A J Vyse; F Enquselassie; W Nigatu; D J Nokes
Journal:  Epidemiol Infect       Date:  2003-04       Impact factor: 2.451

5.  Evaluation of commercial assay detecting specific immunoglobulin g in oral fluid for determining measles immunity in vaccinees.

Authors:  Jacques R Kremer; Claude P Muller
Journal:  Clin Diagn Lab Immunol       Date:  2005-05

6.  Declining population immunity to mumps among Israeli military recruits.

Authors:  Michael Huerta; Nadav Davidovitch; Yair Aboudy; Omer E Ankol; Ran D Balicer; Salman Zarka; Itamar Grotto
Journal:  Vaccine       Date:  2006-06-09       Impact factor: 3.641

7.  Sero-epidemiology of mumps in western Europe.

Authors:  A Nardone; R G Pebody; S van den Hof; D Levy-Bruhl; A M Plesner; M C Rota; A Tischer; N Andrews; G Berbers; P Crovari; W J Edmunds; G Gabutti; P Saliou; E Miller
Journal:  Epidemiol Infect       Date:  2003-08       Impact factor: 2.451

8.  Serological and molecular epidemiology of measles virus outbreaks reported in Ethiopia during 2000-2004.

Authors:  W Nigatu; D J Nokes; A Afework; D W G Brown; F T Cutts; L Jin
Journal:  J Med Virol       Date:  2006-12       Impact factor: 2.327

9.  Salivary diagnosis of measles: a study of notified cases in the United Kingdom, 1991-3.

Authors:  D W Brown; M E Ramsay; A F Richards; E Miller
Journal:  BMJ       Date:  1994-04-16

10.  Sensitive assays for viral antibodies in saliva: an alternative to tests on serum.

Authors:  J V Parry; K R Perry; P P Mortimer
Journal:  Lancet       Date:  1987-07-11       Impact factor: 79.321

View more
  10 in total

1.  Evaluation of biological sample preparation for immunosignature-based diagnostics.

Authors:  Brian Andrew Chase; Stephen Albert Johnston; Joseph Barten Legutki
Journal:  Clin Vaccine Immunol       Date:  2012-01-11

2.  Assessment of mumps virus-specific antibodies by different serological assays: which test correlates best with mumps immunity?

Authors:  R Allwinn; B Zeidler; K Steinhagen; E Rohwäder; S Wicker; H F Rabenau; H W Doerr
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2011-04-01       Impact factor: 3.267

3.  Response to third rubella vaccine dose.

Authors:  Lotta Siira; Hanne Nøkleby; Regine Barlinn; Øystein R Riise; Ingeborg S Aaberge; Susanne G Dudman
Journal:  Hum Vaccin Immunother       Date:  2018-06-21       Impact factor: 3.452

4.  Bayesian inference for skew-normal mixture models with left-censoring.

Authors:  Getachew A Dagne
Journal:  J Biopharm Stat       Date:  2013       Impact factor: 1.051

Review 5.  Saliva diagnostics - Current views and directions.

Authors:  Karolina Elżbieta Kaczor-Urbanowicz; Carmen Martin Carreras-Presas; Katri Aro; Michael Tu; Franklin Garcia-Godoy; David Tw Wong
Journal:  Exp Biol Med (Maywood)       Date:  2016-12-08

Review 6.  Application of Oral Fluid Assays in Support of Mumps, Rubella and Varicella Control Programs.

Authors:  Peter A C Maple
Journal:  Vaccines (Basel)       Date:  2015-12-09

7.  Measles vaccination coverage estimates from surveys, clinic records, and immune markers in oral fluid and blood: a population-based cross-sectional study.

Authors:  Kyla T Hayford; Mohammed S Shomik; Hassan M Al-Emran; William J Moss; David Bishai; Orin S Levine
Journal:  BMC Public Health       Date:  2013-12-20       Impact factor: 3.295

Review 8.  Salivary Diagnostics in Pediatrics: Applicability, Translatability, and Limitations.

Authors:  Mona Hassaneen; Jill L Maron
Journal:  Front Public Health       Date:  2017-04-20

9.  Assessment of measles immunity among infants in Maputo City, Mozambique.

Authors:  Jagrati V Jani; Carol Holm-Hansen; Tufária Mussá; Arlinda Zango; Ivan Manhiça; Gunnar Bjune; Ilesh V Jani
Journal:  BMC Public Health       Date:  2008-11-12       Impact factor: 3.295

Review 10.  Public health responses during measles outbreaks in elimination settings: Strategies and challenges.

Authors:  Paul A Gastañaduy; Emily Banerjee; Chas DeBolt; Pamela Bravo-Alcántara; Samia A Samad; Desiree Pastor; Paul A Rota; Manisha Patel; Natasha S Crowcroft; David N Durrheim
Journal:  Hum Vaccin Immunother       Date:  2018-07-11       Impact factor: 3.452

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.